Research publishes now. Order routing opens after regulatory clarity. Data depth expands continuously. The staging below is how we're sequencing the build — reviewed as regulatory and supply-chain conditions change.
Research publishes continuously. The /chat citation-first assistant is live against the production corpus. Waitlist is open — Founding 20 lifetime slots are scarce; everyone past position 20 still earns lifetime Pro after $1k routed.
One-click multi-vendor carts, transparent batch selection, and the flat consolidation fee described on /pricing. Ships behind regulatory clarity in the US FDA's Pharmacy Compounding Advisory Committee (PCAC) consultation window.
Public vendor leaderboard. Community sentiment dashboard surfacing forum and chat signal alongside COA data. Expanded compound coverage — starting with BPC-157 and TB-500 depth parity to the existing GLP-1 / GHRH archives.
Meso, excelmale, and promuscle ingested into the forum corpus. Discord archive folded into the public research surface. Multi-jurisdiction coverage (UK, EU, CA) with jurisdiction-specific pricing and routing logic.